The most well studied dose of
LupronLupron
Lupron depot
Lupron depot-gyn
Lupron depot-ped for breast cancer is 3.6 mg monthly. The longer acting formulations have mostly been studied in prostate cancer, however, are sometimes substituted for the monthly formulation for patient convenience. While the 11.5 mg dose every 3 months correlates more closely with the 3.6 mg monthly dose, some patients may require different dosing schedules for adequate suppression of ovarian function. You may wish to discuss this further with your oncologist.